CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 33 enrolled / 33 target
Drug / intervention
Voltaren® Schmerzgel forte; 2.32% (Test Product)drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06954181
NCT06954181N/ACompletedHigh Momentum (2.2/mo)Completion was 14mo ago

Quantification of Diclofenac 2.32% (Voltaren) in Rinse Water After Different Application Methods

HALEON·interventional·Posted May 1, 2025·Updated Jun 16, 2026

In Brief

A clinical study evaluating Voltaren® Schmerzgel forte; 2.32% (Test Product) for Healthy Participants. Completed, enrolled 33 participants across 1 site.

Signals

Enrolling ahead of pace

Detailed Summary

The purpose of this study is to quantify the amount of diclofenac in rinse water after application of the test product (Voltaren® Schmerzgel forte; 2.32 percent \[%\]) containing 2.32% Diclofenac-N-Ethylethanamin either by hand or using an applicator and subsequent washing and/or wiping.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
2026
First PostedMay 1, 2025
Enrollment StartMar 26, 2025
Primary CompletionApr 11, 2025
TodayJul 2, 2026
Enrollment to primary: 15 daysPosted 1.2 years ago

Arms & Interventions

Voltaren® Schmerzgel forte; 2.32% Applied Without Applicator (Method 1)experimental

Participants will apply the test product (Voltaren® Schmerzgel forte; 2.32%) topically on the assigned test area (left or right elbow, depending on the handedness of the participant) using 3 different methods, once on Days 1, 3 and 5 as per crossover assignment. There will be a washout period of at least 2 days between each method. Method 1: Participants will apply the test product on the assigned test area with one hand by gently massaging in for 60 seconds and will wash their hands and 5 minutes after application, will wash the test area according to the washing procedure on Days 1, 3 and 5 as per crossover assignment. The water of each washing step will be collected separately.

Drug: Voltaren® Schmerzgel forte; 2.32% (Test Product)
Voltaren® Schmerzgel forte; 2.32% Applied With Applicator (Method 2)experimental

Participants will apply the test product (Voltaren® Schmerzgel forte; 2.32%) topically on the assigned test area (left or right elbow, depending on the handedness of the participant) using 3 different methods, once on Days 1, 3 and 5 as per crossover assignment. There will be a washout period of at least 2 days between each method. Method 2: Participants will apply the test product on the assigned test area with the applicator, followed by washing the test area 5 minutes after application (1st washing) and 5 minutes after 1st washing (2nd washing) on Days 1, 3 and 5 as per crossover assignment. The water of each washing step will be collected separately.

Drug: Voltaren® Schmerzgel forte; 2.32% (Test Product)
Voltaren® Schmerzgel forte; 2.32% Applied With Applicator (Method 3)experimental

Participants will apply the test product (Voltaren® Schmerzgel forte; 2.32%) topically on the assigned test area (left or right elbow, depending on the handedness of the participant) using 3 different methods, once on Days 1, 3 and 5 as per crossover assignment. There will be a washout period of at least 2 days between each method. Method 3: Participants will apply the test product on the assigned test area with the applicator followed by wiping the test area with a paper towel and washing the test area and hands according to the washing procedure after 5 minutes of application on Days 1, 3 and 5 as per crossover assignment. The water of the washing step will be collected.

Drug: Voltaren® Schmerzgel forte; 2.32% (Test Product)

Interventions

Voltaren® Schmerzgel forte; 2.32% (Test Product)drug

Voltaren® Schmerzgel forte; 2.32% containing 2.32% Diclofenac-N-Ethylethanamin.